From Sandbox to Safety: Salvaging a Biotech AE Reporting Pilot with n8n and Agentic AI

From Sandbox to Safety: Salvaging a Biotech AE Reporting Pilot with n8n and Agentic AI

1. Problem / Context

A Phase II biotech (about $90M revenue) running a two-site clinical trial faced a familiar pharmacovigilance crunch: adverse events (AEs) arrived through site emails and portal uploads, while a lean safety team had to code events and submit regulatory reports under 7- and 15-day clocks. Manual triage and coding placed timelines at risk, and every missed clock meant potential findings under FDA and EMA oversight. An earlier RPA pilot—built to scrape forms and push records—broke when the EDC vendor issued a routine version update. With brittle scripts and no change-control pathway, the “pilot” stayed stuck in the sandbox and never returned to production.

This case study shows how agentic AI (to interpret narrative AEs and propose MedDRA codes) combined with n8n (to orchestrate SLAs, escalations, and traceability) moved the organization from pilot purgatory to validated production—with zero missed safety clocks across two consecutive quarters.

2. Key Definitions & Concepts

• Adverse Event (AE) intake: Collection of event information from sites via email, portals, and EDC exports.
• MedDRA coding: Standardized medical terminology used to code AEs for consistent analysis and reporting.
• Safety clocks: Regulatory timelines for serious and other reportable events (e.g., 7- or 15-day submissions).
• CIOMS narrative: The structured case narrative used in ICSR reporting packages.
• EDC (Electronic Data Capture): Trial data system producing exports used by PV teams.
• Agentic AI: A governed automation pattern combining AI reasoning with tools and policies to interpret text, take actions, and coordinate steps with human oversight.
• n8n: An open, extensible workflow orchestrator; in this context, the backbone that enforces SLAs, handles escalations, versions flows for traceability, and coordinates system handoffs.

3. Why This Matters for Mid-Market Regulated Firms

Mid-market biotechs run lean. Safety and clinical ops leaders balance cost pressure, audit scrutiny, and limited specialist bandwidth. They must hit regulatory timelines without ballooning vendor spend or adding headcount. Traditional RPA can automate clicks, but it struggles with narrative interpretation and breaks under upstream system changes. Agentic AI, orchestrated with n8n, brings three advantages:

1. Understanding: It reads free-text AE emails and EDC notes, proposing plausible MedDRA terms.
2. Control: n8n enforces timers, handoffs, and sign-offs with a clear audit trail.
3. Resilience: Versioned flows, contract tests, and governed connectors reduce breakage when systems update.

For organizations operating under FDA/EMA expectations, the combination delivers both speed and defensibility.

4. Practical Implementation Steps / Roadmap

1. Connect intake channels: Use governed connectors to ingest site emails, portal attachments, and scheduled EDC exports into a secure queue.
2. Normalize and de-duplicate: Standardize headers, attach site identifiers, and merge duplicates to establish a clean case intake record.
3. Agentic parsing: AI agents extract key fields (patient age/sex, suspect product, onset date, seriousness criteria) and highlight narrative evidence. Confidence scores and rationale are attached to every proposed field.
4. MedDRA code proposals: The agent proposes PT/LLT codes (with version metadata), citing supporting text spans. Human reviewers can accept or adjust with one click.
5. Safety clock initiation: Based on seriousness and expectedness, n8n starts the appropriate regulatory timer, pre-populates due dates, and alerts owners.
6. Human-in-the-loop review: A safety reviewer validates extractions, confirms MedDRA codes, and triggers CIOMS narrative drafting. All actions are recorded with timestamps and user IDs.
7. CIOMS draft generation: The agent composes a structured narrative; n8n enforces required sections and completeness checks before submission packaging.
8. SLA enforcement and escalation: n8n monitors queues, sends reminders, escalates overdue tasks to safety leads, and triggers contingency workflows when clocks approach thresholds.
9. Submission assembly and dispatch: The system packages the ICSR with attachments and sends via approved channels. Hand-offs to safety databases and archives are logged.
10. Post-submission logging and learning: Audit-ready logs capture the end-to-end trail. Reviewer feedback retrains the coding/rationale components under controlled change management.

Kriv AI, as a governed AI and agentic automation partner for the mid-market, often stands up this pattern with production-grade staging, data readiness checks, and MLOps scaffolding so lean PV teams can maintain velocity without sacrificing compliance.

5. Governance, Compliance & Risk Controls Needed

• Data boundaries and minimization: Route only the minimum necessary PHI/PII to AI components; keep regulated identifiers encrypted at rest and in transit.
• Access control and Part 11 alignment: Enforce role-based access, e-signatures, and time-stamped audit trails for all critical actions and approvals.
• Model risk management: Maintain versioned models, document intended use, monitor drift, and put human review at decision points (coding, narrative, submission release).
• Change control and validation: Use staging environments, contract tests against EDC and email schemas, and validation protocols before promoting changes.
• Traceability: n8n’s flow versioning and execution logs provide evidence for audits—who did what, when, and why—down to the MedDRA version used.
• Vendor lock-in mitigation: Favor open connectors and exportable logs; isolate model endpoints behind governed interfaces to swap components without re-architecting.

Kriv AI helps mid-market teams operationalize these controls—combining governance frameworks with practical delivery—so agentic workflows remain auditable and resilient.

6. ROI & Metrics

This biotech realized measurable, defensible outcomes within two quarters:

• On-time reporting rate: +32% improvement, driven by SLA timers, escalations, and faster narrative preparation.
• Regulatory clock performance: 0 missed clocks across two consecutive quarters.
• Rework reduced: 28% fewer back-and-forth cycles due to clearer rationale for MedDRA choices and standardized narratives.
• Cycle time: Intake-to-submission cycle shortened by hours per case as manual extraction and formatting fell away.
• First-pass coding accuracy: Reviewer acceptance rates increased as agents surfaced text evidence for each proposed code.
• Labor savings: Reallocated safety analyst hours to clinical signal review versus email triage.
• Payback period: With a small footprint (two sites) and lean team, benefits accrued quickly, avoiding the cost of additional headcount or expensive bespoke platforms.

7. Common Pitfalls & How to Avoid Them

• Brittle automations: RPA scripts tied to page layouts break on EDC updates. Use agentic parsing with contract-tested connectors and versioned flows.
• Black-box AI: Lack of rationale undermines trust. Require evidence-linked extractions and code proposals with human sign-off.
• Sandbox stagnation: Pilots that never cross validation gates create sunk cost. Establish production-grade staging and change control from day one.
• Missing safety-clock logic: If clocks aren’t explicit, tasks slip. Start clocks automatically based on seriousness criteria and track due dates centrally.
• Over-automation: Keep humans in the loop for coding and submission release, especially early in rollout.
• Audit blind spots: Without execution logs, investigations stall. Ensure end-to-end logging and immutable archives.

30/60/90-Day Start Plan

First 30 Days

• Discovery and workflow inventory: Map AE intake sources, coding steps, narratives, and submission channels.
• Data checks: Confirm email/portal/EDC export formats, PII/PHI handling, and MedDRA version alignment.
• Governance boundaries: Define roles, approvals, and human-in-the-loop points; outline Part 11 controls and audit log requirements.
• Environment setup: Stand up n8n in a governed environment; create staging and production lanes with access controls.

Days 31–60

• Pilot workflows: Implement intake normalization, agentic extraction, and MedDRA proposal with reviewer UI.
• Orchestration: Configure safety clocks, SLA timers, and escalations in n8n; add CIOMS draft generation.
• Security controls: Enforce RBAC, e-signatures for key steps, and encrypted storage; begin contract tests against EDC and email schemas.
• Evaluation: Track cycle time, on-time rate, and reviewer acceptance of codes; refine prompts and rules.

Days 61–90

• Scaling: Expand to additional AE sources or sites; tune queues for throughput.
• Monitoring: Add dashboards for clock adherence, rework rate, and change-control events; set alerting for drift or failure.
• Documentation and validation: Complete validation packets and SOP updates; prepare audit-ready safety logs.
• Stakeholder alignment: Share results with clinical, quality, and compliance leaders; define the roadmap for broader PV automation.

9. Industry-Specific Considerations

• Seriousness-driven logic: Ensure clocks align with serious and unexpected event criteria and the correct 7-/15-day timelines.
• MedDRA versioning: Lock and document the MedDRA release in use for the trial; plan for version updates under change control.
• Global submissions: If applicable, prepare routing for different authorities and formats; keep transmission proofs in the audit trail.
• Site variability: Normalize free-text patterns across sites; use templates to reduce narrative inconsistency.

10. Conclusion / Next Steps

By pairing agentic AI for interpretation with n8n for orchestration and traceability, a lean Phase II biotech rescued a broken pilot and achieved reliable, compliant AE reporting—faster and with fewer errors. The key was building for production from day one: governed connectors, contract tests, human-in-the-loop checkpoints, and audit-ready safety logs.

If you’re exploring governed Agentic AI for your mid-market organization, Kriv AI can serve as your operational and governance backbone—helping with data readiness, MLOps, and workflow orchestration so PV teams can meet regulatory expectations without adding heavy overhead.